SAB Biotherapeutics, Inc.

Q4 2025 13F Holders

Symbol
SABS
CUSIP
78397T202
Type
Equity
Class
COM NEW
Num filings
48
Total reported value, excl. options
$136 M
Manager Report Date Value ($000) Shares Option Type